Agilon Health sets a target valuation of up to $9 billion in its IPO

On Wednesday, Agilon Health said it was aiming for a valuation of up to $9 billion in its initial public offering (IPO). With its IPO the healthcare platform would join a clutch of companies looking to cash in on the record run in U.S. capital markets. In a report released by the company, it said it planned to raise more than $1 billion in its IPO by selling 46.6 million shares. The company has planned to sell its shares at a price range of $20 and $23 per share.

The company was founded in 2016. According to its website, Agilon health provides a care platform for primary care physicians. In a regulatory filing, The company will list on the New York Stock Exchange under the symbol “AGL.” JP Morgan, Goldman Sachs, and BofA are among the underwriters for the offering.

According to the company’s website, “Agilon health is built for physicians by physicians, as the patient-physician relationship is the cornerstone of care.” The company has a unique method that allows primary care physicians to take the long view of their relationships with patients, and to be confident in the long-term financial viability of their practices. The company follows a Total Care Model that maintains the independence of physicians. CEO of Agilon, Steve Sell said, “our vision is to transform the future of healthcare in communities across the country by empowering exceptional patient-physician relationships.”